Greedy Insider
TVTX Insider Trades and Greediness Scores
Travere Therapeutics, Inc. (TVTX) insider trades: since Dec 1, 2025, Greedy Insider recorded 0 open-market buys and 118 sales on Form 4 from 11 insiders. The strongest recent filing scored 94 (Strong).
Who bought and who sold
Across the last 118 scoreable Form 4 transactions in TVTX, 0 were open-market purchases and 118 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Dube Eric M | CEO | Sell | 128065.0 | 6783244.5 | 2026-10-15 | 78 | View |
| Dube Eric M | CEO | Sell | 37270.0 | 2020022.9 | 2026-10-15 | 69 | View |
| Dube Eric M | CEO | Sell | 78400.0 | 4313403.5 | 2026-10-15 | 75 | View |
| Dube Eric M | CEO | Sell | 6802.0 | 441795.34 | 2026-09-17 | 75 | View |
| Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 8282.0 | 538917.2 | 2026-09-17 | 77 | View |
| Dube Eric M | CEO | Sell | 101691.0 | 6567876.0 | 2026-09-17 | 93 | View |
| Dube Eric M | CEO | Sell | 99716.0 | 6307964.5 | 2026-09-16 | 92 | View |
| Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 93604.0 | 5920181.5 | 2026-09-16 | 94 | View |
| Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 79113.0 | 5035906.5 | 2026-09-16 | 93 | View |
| ROTE WILLIAM E. | Chief Research Officer | Sell | 65104.0 | 4109397.0 | 2026-09-16 | 91 | View |
The strongest recent filing
Heerma Peter (EVP, CHIEF COMMERCIAL OFFICER) sold 93,604 shares of Travere Therapeutics, Inc. on Sep 16, 2026, a filing that scored 94 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 8 insiders (Dube Eric M, Heerma Peter, ROTE WILLIAM E., Calvin Sandra) traded TVTX the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Travere Therapeutics, Inc.'s own history
Open-market buys make up 0% of the 118 scoreable TVTX transactions on record between Dec 1, 2025 and Oct 15, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 118
- Open-market buys: 0
- Sales: 118
- Distinct insiders: 11
- Strongest recent Greediness Score: 94 (Strong)
Primary sources
Related
- Strongest filing
- TVTX in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.